United Therapeutics
UTHR
#994
Rank
S$29.88 B
Marketcap
S$660.81
Share price
0.82%
Change (1 day)
33.55%
Change (1 year)

EPS for United Therapeutics (UTHR)

EPS in 2025 (TTM): S$37.50

According to United Therapeutics's latest financial reports the company's current EPS (TTM) is S$36.61. In 2024 the company made an earnings per share (EPS) of S$33.96 an increase over its 2023 EPS that were of S$27.04.

EPS history for United Therapeutics from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$37.5010.41%
2024S$33.9625.59%
2023S$27.0431.54%
2022S$20.5651.18%
2021S$13.60-9.1%
2020S$14.96-581.4%
2019S-$3.11-117.79%
2018S$17.4642.11%
2017S$12.29-40.93%
2016S$20.8013.45%
2015S$18.34104.29%
2014S$8.98100.29%
2013S$4.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eli Lilly
LLY
S$26.35-28.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$8.37-77.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$0.81-97.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
S$2.21-93.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S-$0.85-102.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
S-$8.08-122.06%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$4.62-87.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cardinal Health
CAH
S$8.55-76.64%๐Ÿ‡บ๐Ÿ‡ธ USA